ANNALS OF THE RHEUMATIC DISEASES, cilt.79, sa.1, ss.19-30, 2020 (SCI-Expanded, Scopus)
Background Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have the potential to change clinical care and therefore supporting the need to update the original recommendations.